These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38178285)
1. UK PID Patients: Overview of perception on IgRT and infections using short survey. Hodkinson JP; Griffiths PR; Narme AMI; Staiger C Pharmazie; 2023 Dec; 78(11):231-237. PubMed ID: 38178285 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin use in immune deficiency in the UK: a report of the UKPID and National Immunoglobulin Databases. Shillitoe B; Hollingsworth R; Foster M; Garcez T; Guzman D; Edgar JD; Buckland M Clin Med (Lond); 2018 Oct; 18(5):364-370. PubMed ID: 30287427 [TBL] [Abstract][Full Text] [Related]
3. Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages". Bienvenu B; Cozon G; Hoarau C; Pasquet M; Cherin P; Clerson P; Hachulla E; Crave JC; Delain JC; Jaussaud R Orphanet J Rare Dis; 2016 Jun; 11(1):83. PubMed ID: 27334100 [TBL] [Abstract][Full Text] [Related]
4. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies. Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785 [TBL] [Abstract][Full Text] [Related]
5. Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections. Lahue BJ; Mallick R; Zhang X; Heidt J; Song Y; Koenig AS; Espinoza G Immunotherapy; 2022 Oct; 14(15):1245-1261. PubMed ID: 35971794 [TBL] [Abstract][Full Text] [Related]
6. British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy. Grigoriadou S; Clubbe R; Garcez T; Huissoon A; Grosse-Kreul D; Jolles S; Henderson K; Edmonds J; Lowe D; Bethune C Clin Exp Immunol; 2022 Oct; 210(1):1-13. PubMed ID: 35924867 [TBL] [Abstract][Full Text] [Related]
7. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET). Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201 [TBL] [Abstract][Full Text] [Related]
8. A summertime pause in immunoglobulin replacement therapy: a prospective real-world analysis. Hémar V; Rivière E; Greib C; Machelart I; Roucoules M; Prot C; Pellegrin JL; Viallard JF; Lazaro E Immunotherapy; 2021 Dec; 13(18):1491-1499. PubMed ID: 34743547 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment. Wasserman RL Allergy Asthma Proc; 2021 Nov; 42(6):489-494. PubMed ID: 34871156 [No Abstract] [Full Text] [Related]
10. Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review. Wijetilleka S; Mukhtyar C; Jayne D; Ala A; Bright P; Chinoy H; Harper L; Kazmi M; Kiani-Alikhan S; Li C; Misbah S; Oni L; Price-Kuehne F; Salama A; Workman S; Wrench D; Karim MY Autoimmun Rev; 2019 May; 18(5):535-541. PubMed ID: 30844552 [TBL] [Abstract][Full Text] [Related]
11. The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation. Baumann U; Routes JM; Soler-Palacín P; Jolles S Front Immunol; 2018; 9():1837. PubMed ID: 30147696 [TBL] [Abstract][Full Text] [Related]
12. Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study. Guerola LDC; Sacristán AAG; Portolés A; Jasso M; Guerra-Galán T; de la Fuente-Munoz E; Palacios-Ortega M; Fernández-Arquero M; Cuesta-Mínguez C; Rodríguez-Sanz A; Peña-Cortijo A; Polo M; Morales MM; Anguita-Mandly E; Benítez Jiménez T; Benavente Cuesta C; Sánchez-Ramón S Front Immunol; 2024; 15():1413231. PubMed ID: 38989286 [TBL] [Abstract][Full Text] [Related]
14. Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland. Edgar JDM; Richter AG; Huissoon AP; Kumararatne DS; Baxendale HE; Bethune CA; Garcez T; Misbah SA; Sorensen RU; J Clin Immunol; 2018 Feb; 38(2):204-213. PubMed ID: 29423883 [TBL] [Abstract][Full Text] [Related]
19. A systematic literature review of the effects of immunoglobulin replacement therapy on the burden of secondary immunodeficiency diseases associated with hematological malignancies and stem cell transplants. Monleón Bonet C; Waser N; Cheng K; Tzivelekis S; Edgar JDM; Sánchez-Ramón S Expert Rev Clin Immunol; 2020 Sep; 16(9):911-921. PubMed ID: 32783541 [TBL] [Abstract][Full Text] [Related]
20. Update on the treatment of primary immunodeficiencies. García JM; Español T; Gurbindo MD; Casas C C Allergol Immunopathol (Madr); 2007; 35(5):184-92. PubMed ID: 17923072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]